I am on duty this Spring Festival! A number of enterprises to use the holiday to carry out production, maintenance efforts to achieve a good start in the first quarter
Release time:
2022-02-21
News from our newspaper In the Spring Festival just past, many peak workers either gave up their vacations and stuck to their posts, or ended their vacations ahead of schedule to start work, making efforts to achieve a good start in the first quarter of 2022 .
Spring Festival has always been the overhaul period for peak cement enterprises. This overhaul is the most comprehensive and largest-scale maintenance of cement production lines this year, and plays an important role in the completion of production tasks throughout the year. At the same time, the cement enterprises will also take advantage of this opportunity to focus on a series of technological transformation. To this end, the three cement enterprises have determined the maintenance and technical renovation work plan as early as New Year's Day, and have done a good job in purchasing relevant equipment and spare parts. The personnel of the outsourcing units and the construction time for entering the site have been put in place one by one. According to the different regional market conditions and peak shifting production requirements, enterprises make different arrangements for production, operation and overhaul during the Spring Festival. For example, the overhaul of Huang Ping Jianfeng kiln system starts from # September 20 , while Daye Jianfeng insists on stopping production until 2 (the fourth day of the first lunar month) to prepare sufficient inventory for market sales after the Spring Festival. In order to ensure the orderly progress of the overhaul, most of the competent leaders and technical backbones of various enterprises, except those on duty in the factory, returned to work after only three or four days off. At present, the overhaul work of the three cement enterprises is being carried out in an orderly manner as planned. Among the subordinate enterprises of
pharmaceutical company, Anhui xinbeika chemical co., ltd. organized all its staff to participate in the safety education and training on resumption of work and production after the festival on 2 4 , and the preparatory work such as resumption of prenatal examination and maintenance and on-site cleaning on 2 5 .
As the only window enterprise under the peak, the peak pharmacy will be able to operate normally every day through reasonable arrangement of shifts during the Spring Festival holiday. Although affected by the epidemic and rainy weather this year, the number of customers during the Spring Festival was relatively small compared with the same period last year, and the staff of large pharmacies still stuck to their posts to provide immediate services for citizens to seek medical advice.
(Li Li Liu Feng Zhou Shao and Wang Lijun Bao Qingyuan Chen Jing Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page